0001555280-21-000235.txt : 20210521 0001555280-21-000235.hdr.sgml : 20210521 20210521164151 ACCESSION NUMBER: 0001555280-21-000235 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210519 FILED AS OF DATE: 20210521 DATE AS OF CHANGE: 20210521 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lagano Roxanne CENTRAL INDEX KEY: 0001567878 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35797 FILM NUMBER: 21949696 MAIL ADDRESS: STREET 1: C/O ZOETIS INC. STREET 2: 100 CAMPUS DRIVE CITY: FLORHAM PARK STATE: NJ ZIP: 07940 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zoetis Inc. CENTRAL INDEX KEY: 0001555280 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 460696167 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 973-822-7000 MAIL ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 4 1 wf-form4_162162968922886.xml FORM 4 X0306 4 2021-05-19 0 0001555280 Zoetis Inc. ZTS 0001567878 Lagano Roxanne C/O ZOETIS INC. 10 SYLVAN WAY PARSIPPANY NJ 07054 0 1 0 0 Executive Vice President Common Stock 2021-05-19 4 M 0 1362 41.83 A 43445 D Common Stock 2021-05-19 4 M 0 4638 55.02 A 48083 D Common Stock 2021-05-19 4 S 0 6000 169.05 D 42083 D Stock Option 2021-05-19 4 M 0 1362 0 D Common Stock 1362.0 58342 D Stock Option 2021-05-19 4 M 0 4638 0 D Common Stock 4638.0 53704 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020. The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. 1,362 options granted February 19, 2016 at an exercise price of $41.83 per option. Each option vests on the third anniversary of the date of grant. Each option expires on the tenth anniversary of the date of grant. 17,482 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; 12,052 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; and 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option. 4,638 options granted February 14, 2017 at an exercise price of $55.02 per option. 12,844 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; 12,052 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; and 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option. /s/ Brenda Santuccio, as Attorney-in-Fact 2021-05-21